Plain-English translation of NCT06262516 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is comparing two surgical approaches for treating upper tract urothelial carcinoma, a rare cancer that starts in the tubes connecting the kidneys to the bladder. All participants will have their affected kidney and ureter removed, but some will also have nearby lymph nodes removed during the same surgery, while others will not. Researchers want to find out whether removing the lymph nodes helps prevent cancer from coming back.
Currently, doctors sometimes remove lymph nodes during this surgery as a precaution, even when imaging doesn't show signs of cancer spread, but no large research study has proven whether this extra step actually helps patients live longer or stay cancer-free. This trial will provide clear answers about whether this additional surgery is worth doing.
You likely qualify if…
You likely don't qualify if…
You will undergo the standard kidney removal surgery that your doctor has already recommended. At the time of surgery, you will be randomly assigned to either have your nearby lymph nodes removed or not removed. After surgery, researchers will follow your health and watch for signs of cancer recurrence over at least two years, tracking whether the cancer comes back and comparing outcomes between the two groups.
AI-generated summary from trial data · Jun 7, 2026 · Not medical advice
United States